Gabriela Ecco

What they invest in

Gabriela Ecco is a Senior Associate at ND Capital, a venture capital firm investing across disruptive technologies in life, physical, and data sciences. ND Capital's investment thesis revolves around the convergence of scientific disciplines leading to breakthroughs. They focus on nurturing their portfolio companies by fostering creativity, intellect, and passion while aiming to build long-lasting impactful businesses. With a third fund of $335 million fully invested and a fourth fund in progress, ND Capital invests across sectors and technologies at various stages. They operate in the United States and Europe, with teams strategically placed in Silicon Valley, Switzerland, and the Cayman Islands. Gabriela Ecco's track record includes serving as a board observer for companies like EVIR Therapeutics, Vandria, and Osasuna Therapeutics. While specific information on investment check size and partnership styles is limited, her involvement with ND Capital signifies an active role in fostering growth and innovation within the venture capital space.

Who works there

6 people on file: 6 with an email address, 6 with a phone number, 5 with a professional profile. Names and details are behind a free account.

No card. Each contact is charged once and stays yours.